This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Minagawa, M. Articles by White, J. H. Search for Related Content PubMed PubMed Citation Articles by Minagawa, M. Articles by White, J. H.

Dissection of Differentially Regulated (G+C)-Rich Promoters of the Human Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor Gene¹

Departments of Physiology (J.D.B., M.Y.K., F.W.M., J.D., G.N.H., D.G., J.H.W.) and Medicine (M.M., G.N.H., D.G., J.H.W.), McGill University, Montréal, Québec H3G 1Y6, Canada; Calcium Research Laboratory and Royal Victoria Hospital (M.M., G.N.H., D.G.), McGill University, Montréal, Québec H3A 1A1, Canada; and Department of Human Genetics (G.N.H.), McGill University, Montréal, Québec H3A 1B1, Canada

Address all correspondence and requests for reprints to: Dr. John H. White, Department of Physiology, McGill University, McIntyre Building, 3655 Drummond Street, Montréal, Québec H3G 1Y6, Canada. E-mail: jwhite{at}med.mcgill.ca

The PTH/PTH-related peptide (PTHrP) receptor (PTHR) is required for normal skeletal development, and a wide array of physiological responses mediated by PTH and PTHrP. We have previously identified three promoters, P1-P3, which control human PTHR gene transcription. P2 and P3 are (G+C)-rich, function in a number of tissues, lie within the same CpG island, and display many hallmarks of housekeeping promoters. However, they are differentially regulated during development as P2, but not P3, functions in fetal tissues. Here, we have used both stably and transiently transfected human osteoblast-like cells to delineate regions of P2 and P3 required for promoter activity. Deletion analyses performed in stably transfected cells indicated that sequences extending from -91 to -12 relative to the transcription start site were required for function of the P2 promoter. No negative regulatory elements were detected in P2. In contrast, deletion of an A-rich region of P3 extending from -147 to -115 was required for optimal basal activity, suggesting that this sequence acts as a repressor of P3. Strikingly, however, whereas the A-rich region also functioned as a negative element when inserted upstream of the (G+C)-rich P2 promoter, it enhanced expression from the thymidine kinase promoter, suggesting that its function depends on other transcription factors bound to promoter sequences. Fine deletion of P3 sequences proximal to -115 implicated Sp1 motifs and downstream initiation sites in P3 function. These studies indicate that function of P2 and P3 is controlled by ubiquitously expressed transcription factors and raise the possibility that P3 activity is repressed during fetal development.

This article has been cited by other articles:

				M. Minagawa, T. Yasuda, T. Watanabe, K. Minamitani, Y. Takahashi, D. Goltzman, J. H. White, G. N. Hendy, and Y. Kohno Association between AAAG Repeat Polymorphism in the P3 Promoter of the Human Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor Gene and Adult Height, Urinary Pyridinoline Excretion, and Promoter Activity J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1791 - 1796. [Abstract] [Full Text] [PDF]

				M. Minagawa, T. Watanabe, Y. Kohno, H. Mochizuki, G. N. Hendy, D. Goltzman, J. H. White, and T. Yasuda Analysis of the P3 Promoter of the Human Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor Gene in Pseudohypoparathyroidism Type 1b J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1394 - 1397. [Abstract] [Full Text]